– Ten63’s AI/ML Platform Will be Applied to Multiple Disease Areas of Focus within Boehringer’s Research and Development Portfolio – DURHAM, N.C., Dec. 6, 2023 /PRNewswire/ — Ten63 Therapeutics, a biotechnology company unlocking previously undruggable targets by leveraging proprietary…
This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.